Atrial fibrillation (AF) has been treated surgically either concomitantly or as an isolated procedure for over 30 years. A decade or so ago the first consensus statement supporting surgical ablation for AF was published. 1 Since then more societal guidelines have been published recommending a very high class of indication for surgical ablation for AF. [2] [3] [4] The on-pump Cox maze procedure results in higher single-procedure success rate and stroke reduction than any catheter and/or off-pump surgical ablation. 5 However, the perception is that on-pump cardiac surgical procedures are more invasive and are associated with higher periprocedural morbidity and long-term lingering effects when compared to off-pump procedures. Recent data do not support this perception and it is also clear that in the case of AF, careful patient selection is needed.
How to Select and Manage Patients for Surgical Ablation?

Understand the Indications for the Procedure
Patients with AF have a wide variability of clinical presentations. Ablation procedures in general, and surgical procedures in particular, should be reserved only for symptomatic patients. Symptoms of AF can be from palpitations, anxiety, and depression to heart failure symptoms. 10 Patients need to be evaluated thoroughly, prior to the decision to refer them for stand-alone surgical ablation per the guidelines. 2 
Understand the Patient History and Previous Interventions
Most of the patients who are referred for a surgical procedure have failed medical therapy with or without electrical cardioversion and one or more catheter ablation procedures. While patients may opt to have a surgical procedure without having a failed catheter ablation procedure, a comprehensive discussion on the pros and cons of the different interventions should take place. In no circumstances should patients have a surgical intervention without failing drug therapy.
Surgeons should be familiar with the type of catheter ablation procedures and the way they failed in order to conduct a productive discussion with the patient. In the case of patients who failed off-pump surgical procedures and are now seeking a more comprehensive approach such as the Cox maze procedure, surgeons should have knowledge of the different off-pump approaches and be able to communicate the challenges in performing repeat operations, especially minimally invasive ones, due to significant inflammation and adhesions that are to be expected.
Preoperative Imaging
Prior to surgery, patients should have updated imaging. Echocardiography is essential in order to assess the potential for other significant pathologies. Specific aspects of the test that are more relevant to AF are valve disease, intracardiac thrombus, and the size of the right and left atria. Coronary angiogram, according to the guidelines, should never be overlooked. Coronary artery disease is not uncommon in patients who are being screened before the procedure. Coronary anatomy is also important to be identified especially in the vicinity of the mitral valve isthmus and the left atrial appendage. Computed tomography angiography of the chest abdomen and the groin vessels is essential for appropriate planning of the procedure and cannulation strategy.
Discuss Expected Outcome in a Clear Way
Patients who are coming to discuss surgical ablation are usually very informed about AF and are highly motivated to have it cured and be medication free. With that in mind, an honest discussion about the risk of the procedure should take place when all potential complications are mentioned. The procedure should be discussed in detail, as well as the technique for which the left atrial appendage is going to be addressed. Clarifications on the likelihood of atrial arrhythmia to relapse during the first 3 months following the procedure should be made. The follow-up process is important and many patients are eager to have the procedure to avoid long-term anticoagulation. Although this is possible, there are no clear guidelines for surgical patients and in no circumstances should surgeons promise patients that they will come off anticoagulation with no conditions. It should be communicated to the patients that the decision to discontinue anticoagulation is a case-by-case one and is made only after very thorough evaluation of rhythm, function, and the status of the left atrial appendage closure.
How to Choose the Appropriate Surgical Ablation Procedure
It is clear that we should follow common sense and treatment steps that will embrace the concept of the least-invasive approach first. However, we should be able to perform all types of procedures and base our decisions on the patientspecific pathophysiology of AF and patient preference only. When considering the best option for patients, there are 3 key variables:
Type of AF: There are 3 different types of AF in patients referred for intervention, which are paroxysmal, persistent, and long-standing persistent AF. 2 In general, the perception is that the different types of AF also represent a scale of complexity in treating the arrhythmia, with paroxysmal AF the easiest to treat. This rule should never be used until after all aspects of AF have been reviewed and weighed. Therefore, pulmonary vein isolation only may not be as effective as expected in some patients with paroxysmal AF, especially those who have larger left atria and longer duration of AF. In addition, pulmonary vein isolation alone is less effective in patients with concomitant AF secondary to left heart disease than in patients with so-called "stand-alone" paroxysmal AF. II. Duration of AF: In recent years the duration of AF has been recognized as the most important predictor for ablation failure both for the surgical and catheter-based approaches. It is important for surgeons to recognize this variable and incorporate it in their decision-making when choosing the optimal procedure for their patients. In general, the longer AF has been present, the less chance we have of effectively treating patients with a limited lesion set. 11,12 III. Left atrial size: Left atrial size is an important marker for the complexity of AF. Larger atrial size in general (right or left) is usually associated with a longer duration of AF and in patients with nonparoxysmal AF. The significance of large left atrial size (LA >5.5 in diameter) is that if a procedure with a limited number of lesions is chosen, then a higher failure rate is to be expected.
It is evident that in general, a biatrial lesion set is more effective than lesions confined to the left atrium only. 13 This finding is especially important in patients with nonparoxysmal AF, a longer duration of AF, and/or an enlarged left atrium. Although surgeons and electrophysiologists are still debating this issue, multiple publications have demonstrated the very low long-term effectiveness of procedures confined to the pulmonary veins or the left atrium in patients with nonparoxysmal AF. In addition, in recent years, multiple studies have also documented the very low efficacy for catheter ablation procedures confined to the left atrium in patients with nonparoxysmal AF, with a single procedure success rate of 20% or less. 12, 14 Similar results were also documented for surgical ablation when less than a complete biatrial lesion set (Cox maze III/IV) is applied in patients with concomitant procedures or when left atrial surgical ablation only is applied in patients with established risk factors for failure. 15, 16 Unlike concomitant surgical ablation procedures, there is much less comparative evidence between the different stand-alone surgical ablation approaches. It is evident that in North America, there is a push for off-pump surgical procedures especially in places where hybrid approaches can be performed. This is done with little evidence and in many cases with no consideration for the important variables associated with the pathophysiology of AF. There are only a few reports on minimally invasive standalone full maze procedures performed with the use of cardiopulmonary bypass allowing continuous transmural lesions. Those reports demonstrate a very high success rate, excellent safety, and the virtual elimination of long-term strokes. 9,17
How to Choose the Ablation Technology
Always use ablation technology that will create reliable and reproducibly continuous and transmural lesions. Avoid shortcuts and the use of ablation devices that may produce less than an optimal outcome. 3 
How to Conduct the Procedure
Surgical ablation procedures in general, and the Cox maze procedure in particular, are not technically demanding. However, the surgery does require that surgeons be very disciplined. Every lesion should be perfect and a part of the Cox maze pattern. Avoid folds and blood throughout the ablation line when a cryoablation device is applied. Try to avoid very long ablation lines especially when it comes to cryothermal energy (devices allow up to 10 cm lines) in order to maintain full control over the lesion integrity. I very rarely cryoablate segments longer than 5 cm (2 inches). Repeat any lesion for which you have uncertainty regarding its completeness. Conduction block testing (exit and entrance) is very important around the pulmonary veins when bipolar radiofrequency clamps are used. Surgeons should be familiar with the Cox maze III/IV and apply all lesions, including the epicardial coronary sinus lesion and the right atrial lesions carefully and accurately.
Early Postoperative Course and Medications
Following the procedure, patients are followed with serial electrocardiographs (ECGs) and atrial ECGs to document sinus rhythm. Unless contraindicated, all patients are treated with spironolactone (4-6 weeks) and Lasix (10-14 days). 18 Antiarrhythmic therapy is highly recommended and has been associated with a lower rate of atrial arrhythmia early after surgery. Our drug of choice is amiodarone, which is given by mouth for 3 months following surgery when not contraindicated. 19 Oral anticoagulation is recommended in all patients unless contraindicated. The guidelines are not yet clear about a strategy regarding when anticoagulation can be waived early after the procedure. 2 
Follow Your Patients
Patient follow-up is essential to improve outcome and maximize the positive impact of the procedure. Rhythm follow-up should be established with long-term monitoring and not just ECG strips. Event recorders have become very useful in recent years, especially in establishing continuous monitoring that further improves the ability to assess stability of sinus rhythm and the discussion surrounding long-term anticoagulation. Twelve-month follow-up is not sufficient to establish the success of the procedure.
How to Address Rhythm Failure Beyond the Blanking Period
Patients who experience a recurrence of atrial arrhythmias beyond the 90-day blanking period should be treated with the goal to achieve rhythm control before declaring failure. Since the threshold for rhythm failure is only atrial arrhythmia events of 30 s or more, it is very important to keep it in the context of the general burden of atrial arrhythmia. In our experience, half of the recurrences documented throughout the first 5 years are events of 30 s to 5 min, which clinically may be considered success with no real impact on patient symptoms, patient well-being, or the risk of stroke.9 However, symptomatic and longer events of atrial arrhythmia should be approached in a stepwise manner of antiarrhythmic drugs, cardioversion, and in some cases even a touch-up catheter ablation, which has been documented to have very high success rates. 20 In some cases we opt to leave patients on antiarrhythmic drugs for a longer period of time, especially in patients with a very long history of preoperative AF and a large left atrium.
Summary
The Essentials 1. Understand the indications for surgical ablation based on the different guidelines a. Symptoms b. Risk of anticoagulation 2. Be familiar with the surgical ablation devices a. How to use the devices safely to avoid collateral damage and increase efficacy b. Use only devices that will lead to contiguous (no gaps) and uniformly transmural lesions 3. Be familiar and proficient with every surgical ablation approach that results in an acceptable outcome a. Discuss with EP to maximize the success of the intervention b. Patient-centered discussion 4. Patient education and clear expectations 5. Follow your patients and tailor their treatment as needed
Future Directions
There is a need for improvement in 3 different areas:
1. Surgeon education in the pathophysiology of AF and how to perform all surgical ablation procedures. 2. Improvement in surgical ablation devices to allow transmural lesions in a consistent and safe way off and on cardiopulmonary bypass.
A true comparison between all treatment options is required, especially for patients with nonparoxysmal AF.
Future studies should not be centered around specific devices and Food and Drug Administration or CE mark approval processes, but on true clinical questions and long-term efficacy and safety.
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